Latest advanced Therapies
ATMP Market Access: ensuring sustainable patient access to life-changing therapies

How Lightning Health can support you to navigate your access challenges associated with ATMPs

Retrospective analysis of NICE CAR-T therapy single technology appraisals and identification of strategies to minimise time to patient access

In this article, our colleagues Eleanor Butler and Nancy Cross carry out a retrospective review of the NICE CAR-T therapy single technology appraisals

The G-BA implements post launch real world evidence generation for Zolgensma®

Nasos Kipentzoglou, Analyst at Lightning Health reviews the recent approach that the G-BA has taken in requiring the mandatory collection of real world evidence for Zolgensma®

NICE rejects gene therapy Zynteglo

Following NICE draft guidance rejecting Zynteglo, Eleanor Butler, Consultant at Lightning Health explores why the beta thalassaemia treatment is not recommend for routine NHS funding